Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis

25, Aug 2025

2
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis

25, Aug 2025

3
B Cells in the Spotlight: How Ocrelizumab Is Changing the Story of Multiple Sclerosis
Genetics
B Cells in the Spotlight: How Ocrelizumab Is Changing the Story of Multiple Sclerosis

23, Aug 2025

4
A Genetic Brake on Multiple Sclerosis: How SLC9A9 Shapes Treatment Response
Genetics
A Genetic Brake on Multiple Sclerosis: How SLC9A9 Shapes Treatment Response

22, Aug 2025

5
Why Some MS Patients Bounce Back Too Fast: New Clues from African Ancestry Immune Responses
Genetics
Why Some MS Patients Bounce Back Too Fast: New Clues from African Ancestry Immune Responses

22, Aug 2025

Categories:
Genetics
Predicting Glatiramer Acetate Treatment Response in RRMS: A Promising Gene Expression Biomarker Signature
Genetics
Predicting Glatiramer Acetate Treatment Response in RRMS: A Promising Gene Expression Biomarker Signature

25, May 2025

Molecular Code of MS: How RNA Splicing and Inflammation Shape Lesion Stages and Treatment Response
Genetics
Molecular Code of MS: How RNA Splicing and Inflammation Shape Lesion Stages and Treatment Response

27, May 2025

EOMES and TBX21 Expression Reveals Stable, Heritable, and Drug-Sensitive Biomarkers in Multiple Sclerosis
Genetics
EOMES and TBX21 Expression Reveals Stable, Heritable, and Drug-Sensitive Biomarkers in Multiple Sclerosis

27, May 2025

Teaching Computers to Spot Who Will Benefit from Interferon-β in Multiple Sclerosis
Genetics
Teaching Computers to Spot Who Will Benefit from Interferon-β in Multiple Sclerosis

29, May 2025